Trace Genomics

Media and Information Services (B2B)
Current Valuation
N/A
As of December 14, 2018
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series A)

$19.7M

Last Funding
Dec 2018

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
December 14, 2018Early Stage VC (Series A)$19.7MN/A-
Valuation Analysis

Current Valuation Metrics

Trace Genomics is currently valued at N/A as of December 14, 2018.

Track Trace Genomics Valuation Updates

Get notified when Trace Genomics raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Trace Genomics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Trace Genomics Worth in 2026?

Trace Genomics is a leading private company in the Media and Information Services (B2B) sector. Track Trace Genomics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Trace Genomics Valuation is Determined

Private company valuations like Trace Genomics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.